万维提示：
1、该刊只有国际刊号。
2、投稿方式：在线投稿。
3、刊内网址：（202401期）
https://onlinelibrary.wiley.com/journal/27692795
4、投稿系统：https://wiley.atyponrex.com/journal/IBRA
5、主办单位网址：
http://www.zmuhospital.com/Article/Class-334.html
（遵义医科大学附属医院）
6、刊内邮箱：Ibrain@idragon.org.cn
7、官网电话：0851-28608507
8、期刊刊期：季刊，逢季末月出版。
9、微信公众号：遵义医科大学附属医院（ZYykdxffyy）
2024年5月15日星期三
《Ibrain》投稿指南
【官网信息】
Author Guidelines
1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process after Acceptance
8. Post Publication
9. Editorial Office Contact Details
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once the submission materials have been prepared in accordance with the author guidelines, new submissions should be made via the Research Exchange submission portal: https://wiley.atyponrex.com/journal/IBRA.
You may check the status of your submission at any time by logging on to submission.wiley.com and clicking the "My Submissions" button. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.
For editorial enquiries, please contact Ibrain@idragon.org.cn.
Data protection:
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint policy:
Please find the Wiley preprint policy here.
Ibrain will consider articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.
For help with submissions, please contact: Ibrain@idragon.org.cn
2. AIMS AND SCOPE
Ibrain is an international and open access journal in the field of neuroscience. The journal publishes the advanced research about brain function, brain network, brain structure and brain imaging, and provides a communication platform about basic & translational science and clinical practice for neuroscientists. Ibrain welcomes submissions all over the world that will benefit the development of neuroscience.
Ibrain is interested in the topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology or artificial intelligence. The journal is focused on clinical and experimental advances that provide the disease characteristics, pathogenic mechanism or medical techniques.
Topics of interest include, but are not limited to:
Cellular and molecular neuroscience
Regeneration and plasticity
Development and stem cells
Cognition and psychiatric disorders
Neurodegeneration and repair
Neurodegenerative diseases
Stroke
Brain injury
Spinal cord injury
Cerebral ischemia
Brain tumor
Nerve injury
Head injury
Neural circuit
Neural technology
Neuropathy
Cerebral ischemia and hypoxia
Head and face disease
Neuralgia
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Original article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make significant contribution to the scientific knowledge in neuroscience areas. Typically, the research will provide insight into an as yet unknown mechanism or poorly understood process, constitute a highly significant contribution to our understanding of neuroscience, and be of general interest to the neuroscience community. Research articles are typically 6000 words in length, with up to 12 figures and tables in total, and no limitation on the number of references.
Reviews, including systematic reviews and meta-analyses, are typically written by leading experts in the filed within the journal’s scope. Reviews papers help specialists to keep up with the current state of knowledge in a specific research area and provide informative message for non-specialists. Reviews aim to be a critical and concise overview of the most recent advances in a specific research field. Reviews will typically be no limitation on words in length, with up to 8 figures and tables in total, and no limitation on the number of references.
Comments discuss published findings and ideas from a personal viewpoint. They are more forward looking and /or speculative than Reviews. Comments can be submitted either by the invitations from the Editors or by the authors themselves. Both types will undergo the peer-review process prior to acceptance. Comments are typically 3000 words in length, with up to 4 figures and tables in total and no more than 70 references.
Case reports emphasize all aspects of clinical neuroscience. They should describe: (a) unique cases that may represent a previously undescribed condition; (b) unexpected association of two or more diseases; (c) adverse or unexpected treatment response; (d) any other clinical observation based upon well-documented cases that provides important new information; or (e) a new or revised clinical technique or procedure.
Letter provides the rapid and concise report of a novel discovery that is brief in nature and should be of general interest to the field of neuroscience. Letters are typically 1200 words in length excluding, references, figures and tables, with up to 2 figures and tables in total, and no more than 20 references.
Methods are news-style reports, and are published a few times a year to review techniques and technologies in fast-moving fields of research. For further information, contact Ibrain@idragon.org.cn.
4. PREPARING THE SUBMISSION
Cover Letters
Authors may include recommended or non-recommended reviewers in the cover letter. Cover letters are not mandatory; however, they may be supplied at the author’s discretion.
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures.
Main Text File
The text file should be presented in the following order:
A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
A short running title of less than 40 characters;
The full names of the authors;
The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
Abstract and keywords;
Main text;
Ethical statement
Acknowledgments;
Conflict of interest
Funding
Transparency statement
Authors' contribution
References;
Tables (each table complete with title and footnotes);
Figure legends;
Appendices (if relevant).
Figures and supporting information should be supplied as separate files.
For the benefit of the reviewers and editors, please include line numbers in your main text files.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/27692795/homepage/author-guidelines
